News
Select year:
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016
Click here for announcements regarding managers transactions.
Click here for news in Danish.
June 26, 2025 | Press Releases
Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women June 12, 2025 | Press Releases
Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in ChildrenMay 02, 2025 | Press Releases
Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United KingdomMarch 07, 2025 | Press Releases
Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and OlderFebruary 25, 2025 | Press Releases
Bavarian Nordic Partners with Biological E Limited to Expand Global Access to Chikungunya Vaccine December 16, 2024 | Press Releases
Bavarian Nordic Enters License and Manufacturing Agreement for its Mpox Vaccine with Serum Institute of India October 29, 2024 | Press Releases
First Children Vaccinated in New Clinical Study Seeking to Expand the Indication for Bavarian Nordic’s Mpox Vaccine September 19, 2024 | Press Releases
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for AdolescentsSeptember 12, 2024 | Press Releases
Bavarian Nordic Provides Update on the Mpox Vaccine Supply SituationSeptember 05, 2024 | Press Releases
First Doses of Bavarian Nordic’s Mpox Vaccine Now Arriving in the Democratic Republic of CongoAugust 27, 2024 | Press Releases
Bavarian Nordic Receives Approval of Smallpox and Mpox Vaccine in SingaporeAugust 17, 2024 | Press Releases
Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global StakeholdersAugust 16, 2024 | Press Releases
Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to AdolescentsJuly 26, 2024 | Press Releases
Bavarian Nordic Receives Positive CHMP Opinion for Including Mpox Real-world Effectiveness Data in European Marketing Authorization for Smallpox and Mpox VaccineJuly 01, 2024 | Press Releases
Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked LoanJune 28, 2024 | Press Releases
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa May 30, 2024 | Press Releases
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa